Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients

BACKGROUND: The use of oral ribavirin (RBV) for respiratory syncytial virus (RSV) infections is not well studied. With the drastic increase in the cost of aerosolized RBV, we aimed to compare outcomes of hematopoietic cell transplant (HCT) recipients treated with oral or aerosolized RBV for RSV infe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Infect Dis
Hauptverfasser: Foolad, Farnaz, Aitken, Samuel L, Shigle, Terri Lynn, Prayag, Amrita, Ghantoji, Shashank, Ariza-Heredia, Ella, Chemaly, Roy F
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2019
Schlagworte:
Articles and Commentaries
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108094/
https://ncbi.nlm.nih.gov/pubmed/30202920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy760
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge